companydata.dkcompanydata.dk

Processive MedTech Development Services ApS: Financial statements 2025

CVR: 41589604

Source: annual report 2025, Danish Business Authority

01/07/2024 – 30/06/2025

Processive MedTech Development Services ApS (CVR 41589604) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,020,213 and a net result of DKK 333,431 compared with DKK -206,835 the year before. That is an increase of 21.2% compared with the year before. Equity in the 2025 report amounted to DKK 534,798. The solvency ratio was 74%. The company had 2 employees in the financial year.

Gross Profit
DKK 2,020,213
Profit/Loss
DKK 333,431
Equity
DKK 534,798
Total Assets
DKK 723,112
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-2 mio.333 t.535 t.2
2024-1.7 mio.-207 t.201 t.2
2023-2.4 mio.284 t.538 t.2
2022-1.8 mio.357 t.370 t.2
2021-1.5 mio.107 t.147 t.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Processive MedTech Development Services ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About Processive MedTech Development Services ApS

Processive MedTech Development Services ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2020. The company is registered under the industry Anden teknisk rådgivning. The management consists of Maria Lund Jensen and Miles Barnaby Gerrard. The company is owned by Isar Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 2,020,213 and a net result of DKK 333,431 compared with DKK -206,835 the year before. Equity in the 2025 report amounted to DKK 534,798.

Source: annual report 2025, Danish Business Authority

Other financial years